Medline Inc.
MDLN | NASDAQ
$32.12
+$0.12 (+0.37%)
At close: Oct 30, 2026, 4:00 PM ET
$32.11
-$0.01 (-0.03%)
Pre-market:
Nov 2, 2026, 4:22 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Net Income | 1.16B | 1.2B | 234M | -25M |
Depreciation & Amortization | 1.01B | 977M | 951M | 933M |
Stock-Based Compensation | n/a | n/a | n/a | n/a |
Other Working Capital | -237M | 20M | -228M | -245M |
Other Non-Cash Items | 357M | 291M | 325M | 212M |
Deferred Income Tax | n/a | -24M | -24M | -14M |
Change in Working Capital | -783M | -675M | 199M | -919M |
Operating Cash Flow | 1.74B | 1.77B | 1.69B | 187M |
Capital Expenditures | -447M | -364M | -285M | -254M |
Cash Acquisitions | 6M | -1.13B | -16M | -17M |
Purchase of Investments | n/a | n/a | -16M | n/a |
Sales Maturities Of Investments | n/a | n/a | 5M | 7M |
Other Investing Acitivies | -33M | -3M | n/a | n/a |
Investing Cash Flow | -474M | -1.49B | -312M | -264M |
Debt Repayment | -4.09B | -75M | -77M | -61M |
Common Stock Repurchased | -2B | -20M | n/a | n/a |
Dividend Paid | -518M | n/a | -114M | n/a |
Other Financial Acitivies | -36M | -1.52B | n/a | -23M |
Financial Cash Flow | 399M | -1.61B | -191M | -84M |
Net Cash Flow | 1.69B | -1.34B | 1.59B | n/a |
Free Cash Flow | 1.3B | 1.41B | 1.4B | -67M |
Adj. Free Cash Flow | 1.3B | 1.41B | 1.4B | -67M |
Maintenance CapEx | -15.33M | -46.98M | -93.56M | -254M |
Growth CapEx | -431.67M | -317.02M | -191.44M | n/a |
Owner Earnings | 1.73B | 1.72B | 1.59B | -67M |
Add to Watchlist
Select watchlists to add or remove MDLN